🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to look at how people respond to the treatment...
Status
Completed
Location
University of Arkansas for Medical Sciences
Start Date
2007-02
Trial ID
NCT00569231
Treatments Being Tested
Expanded access requests for IFx-Hu2.0 may be considered for the treatment ...
Status
Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT04853602
Treatments Being Tested
Warts can be resistant to treatment or return despite the use of many thera...
Status
Completed
Location
Zagazig university
Start Date
2020-11-20
Trial ID
NCT05254561
Treatments Being Tested
The purpose of this study is to determine whether ADC-1013 (an agonistic hu...
Status
Completed
Location
Center for Cancer Research, Department of Oncology, Herlev Hospital
Start Date
2015-04
Trial ID
NCT02379741
Treatments Being Tested
One hundred patients will receive IFx-Hu2.0 on an outpatient basis at a sin...
Status
Completed
Location
Moore Clinical Research
Start Date
2021-06-10
Trial ID
NCT04925713
Treatments Being Tested
Objective: To compare the efficacy, safety, and recurrence rates of topical...
Status
Completed
Location
Outpatient Clinic of Dermatology, Venereology and Andrology Department at Benha University Hospitals
Start Date
2023-12-01
Trial ID
NCT07329907
intralesional injection of Candida antigens for treating eyelid warts is su...
Status
Completed
Location
Zagazig University
Start Date
2024-06-11
Trial ID
NCT06720467
The goal of this clinical trial is to compare outcome in healthy subjects 1...
Status
Completed
Location
Cahaba Dermatology
Start Date
2025-01-22
Trial ID
NCT05889845
Treatments Being Tested
In this clinical phase I, non-randomized, open-label, uncontrolled, interve...
Status
Completed
Location
USC Norris Comprehensive Cancer Center
Start Date
2020-03-03
Trial ID
NCT04160065
Treatments Being Tested